Open Access Gold möglich sobald Verlagsversion bei der ZB eingereicht worden ist.
		
    Dietary sugars: a fat difference.
        
        J. Clin. Invest. 119, 1089-92 (2009)
    
    
    
				Coronary heart disease is a major cause of morbidity and mortality in Western societies. The metabolic syndrome, characterized by obesity, insulin resistance, elevated blood pressure, elevated triglycerides, and low levels of high-density lipoprotein cholesterol, confers substantial risk of coronary heart disease. Current pathogenetic models suggest that postprandial hyperlipidemia is one specific metabolic abnormality that is typically associated with increased morbidity. In this issue of the JCI, Stanhope and colleagues demonstrate that consumption of fructose-sweetened but not glucose-sweetened beverages for 10 weeks increases de novo lipid synthesis, promotes dyslipidemia, impairs insulin sensitivity, and increases visceral adiposity in overweight or obese adults (see the related article beginning on page 1322).
			
			
		Impact Factor
					Scopus SNIP
					
					
					
					Altmetric
					
				0.000
					4.300
					
					
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
     
     
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2009
    
 
     
    
        HGF-Berichtsjahr
        0
    
 
    
    
        ISSN (print) / ISBN
        0021-9738
    
 
    
        e-ISSN
        1558-8238
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Journal of Clinical Investigation
    
 
		
    
        Quellenangaben
        
	    Band: 119,  
	    Heft: 5,  
	    Seiten: 1089-92 
	    
	    
	
    
 
  
         
        
            Verlag
            American Society of Clinical Investigation
        
 
         
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Institute of Diabetes and Obesity (IDO)
    
 
    
        POF Topic(s)
        30201 - Metabolic Health
    
 
    
        Forschungsfeld(er)
        Helmholtz Diabetes Center
    
 
    
        PSP-Element(e)
        G-502200-001
    
 
     
     	
    
        PubMed ID
        19422101
    
    
        WOS ID
        000265843400011
    
    
        Erfassungsdatum
        2009-05-01